ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269599; 2) Community: the network communities that were significantly associated with the response to NSC 269599; 3) Molecule: the relationships between components within communities and NSC 269599; 4) MDR: the compounds that were significantly associated with the NSC 269599.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.0244632509325736 -0.32312819
NSC 693636 Null 0.0244632509325736 0.020646988
NSC 711745 Null 0.0244632509325736 0.3236405
NSC 716344 Null 0.0244632509325736 0.41492215
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0244632509325736 0.51884527
NSC 735318 Null 0.0244632509325736 0.37162221
NSC 96932 3,3'-Diethyl-9-methylthiacarbocyanine iodide 0.0244632509325736 0.19451171
NSC 267461 Nanaomycin 0.0244718705444135 0.66645915
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0244718705444135 0.66205265
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0244718705444135 0.7244686
Total:115  Current:72    [First] [Prev] [Next] [Last]